King Luther Capital Management Corp Arrowhead Pharmaceuticals, Inc. Transaction History

King Luther Capital Management Corp

  • $21.9 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$58.38 - $84.96 $4.73 Million - $6.88 Million
-80,985 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$61.35 - $90.47 $697,549 - $1.03 Million
11,370 Added 16.33%
80,985 $5.37 Million
Q4 2020

Feb 10, 2021
BUY
$43.82 - $85.37 $3.05 Million - $5.94 Million
69,615 New
69,615 $5.34 Million

Others Institutions Holding ARWR

# of Institutions
296
Shares Held
88.5M
Call Options Held
905K
Put Options Held
387K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.71B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email